(WCIA) — It’s the season for respiratory illnesses ... “So, it’s a variation of a CAPR. It’s just a different fit.” While the old technology worked, they only had two available ...

CAPR’s lead product candidate and only clinical ... weakness and chronic inflammation of the skeletal, heart and respiratory muscles with mortality at a median age of approximately 30 years.

CAPr mtDNA was detectable in many tissues at ... mutants that carry drug resistance and are known to be detrimental to respiratory chain function would have to be used. Successful breeding of ...